With the ability to strategically implement exercise therapy in a way that both complements a patient’s insulin treatment and improves type I myofiber metabolism, clinicians will be able to manage T1DM progression in a way that reduces the impact of insulin resistance through the prescription of regular exercise. This evidence concerns the gene INS and type 1 diabetes mellitus.